• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> REGISTER for our free GMP Newsletter LOGFILE

Image

TOP 5 GMP Downloads

1. GDP Audit Checklist
for the Storage and Transport of Pharmaceuticals

 

2. Quality Agreement
Standard draft to adapt and extend

 

3. Premises
Official requirements | material flow | room classes | and much more...

 

4. GMP Audit Checklist
for Pharmaceutical and API Manufacturers

 

5. Documenting Process Validation
A Drugmaker‘s Guide – step-by-step manual based on real-world examination experience

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to find more Downloads!

News about GMP/cGMP

2012-07-13

EC: Import of Active Substances

The European Commission has published the final template for the written confirmation for active substances exported to the European Union for medicinal products for human use. The new template has been published in Part III of EudraLex, Volume 4.

 

According to Article 46b(2) of Directive 2001/83/EC, active substances shall only be imported if, inter alia, the active substances are accompanied by a written confirmation from the competent authority of the exporting third country which, as regards the plant manufacturing the exported active substance, confirms that the standards of good manufacturing practice and control of the plant are equivalent to those in the Union.

In addition to the template an informative “Questions and Answers document” was published which responds to the most frequently asked questions in relation to the template. Actually listed on a list of third countries which have so far requested to be listed are Switzerland and Israel.

The new rules apply as of 2 July 2013.

Source:

EC: Reference Documents EudraLex - Volume 4

EC: Written Confirmation

EC: Q & A Document

Comments
No comment has yet been written about this news.